Tag Archive: NIH

Applications Now Being Accepted to the Francis S. Collins Scholars Program

The Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research is a key initiative of the Neurofibromatosis Therapeutic Acceleration Program (NTAP) at Johns Hopkins. NTAP (www.n-tap.org) is dedicated to the advancement of research that will improve outcomes for patients with neurofibromatosis type 1 (NF1).  A major need to accomplish this mission is the training and support of clinician scientists who are dedicated to NF1. NTAP launched the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research to address this need. The deadline for the 2019 class application submission is March 15, 2019.  Successful applicants will be notified of … Continue reading

Apply for Sharing Partnership for Innovative Research in Translation (SPIRiT) Award

The Sharing Partnership for Innovative Research in Translation (SPIRiT) is pleased to announce a new funding program that supports pilot research projects representing collaborations between investigators from at least two of the SPIRiT sites. The consortium members include: Johns Hopkins University University of Chicago University of Pennsylvania University of Pittsburgh Washington University in St. Louis Yale University All consortium members are also members of the NIH Clinical and Translational Science Award (CTSA) program. To be eligible for the award, investigator(s) from each of the participating sites must have a significant, defined role in the research project.  Although the participating investigators may have … Continue reading

Johns Hopkins Selected to Chart Genome Variations of 1 Million Americans

Focus will be on historically underrepresented samples in human genetic studies Credit: iStock The National Institutes of Health (NIH) has selected the Johns Hopkins University School of Medicine, Baylor College of Medicine and The University of Texas Health Science Center at Houston to lead one of three “genome centers” for its All of Us Research Program. The Johns Hopkins-Baylor team will receive inaugural funding of $7.9 million to begin collecting and analyzing clinical-grade genomic data from volunteers to understand how biological, environmental and lifestyle factors impact human health. “Creating this enormous data set from diverse populations will build a path to more … Continue reading

Free NIH Training in Neurotherapeutics Discovery and Development Course March 25-28

This training program in neurotherapeutics discovery and development is an intensive 3½ -day course that will provide trainees with the various knowledge elements required to discover and advance a neurotherapeutic agent to Investigational New Drug (IND) Application. Following the course, the training program will continue for a two-year period during which students will have individualized mentoring. The training, which is designed to be applicable to diverse diseases of the nervous system, will equip students with a broad understanding of the various component steps in the neurotherapeutics drug discovery and development process. The 2019 offering will be held at the Bethesda Marriott … Continue reading

2018 Henrietta Lacks Memorial Lecture Includes Surprise Announcement

New Research Building on East Baltimore Campus to Be Named for Henrietta Lacks Images: Joshua Franzos Article: Janet Anderson To cheers, applause and an enthusiastic standing ovation, Johns Hopkins University President Ronald J. Daniels and Paul B. Rothman, dean of the medical faculty and CEO of Johns Hopkins Medicine, announced at the Henrietta Lacks Memorial Lecture on Oct. 6 that a new research building would be named for Henrietta Lacks. The announcement was the highlight at the ninth annual symposium the Institute for Clinical and Translational Research (ICTR) hosts to mark the legacy of the 31-year-old mother of five who … Continue reading

NCATS Funding Opportunity: Pfizer’s Center for Therapeutic Innovation Program

          Proposal Portal Now Open; Pre-Proposals Due November 2   NCATS announces an opportunity for NIH intramural researchers to submit proposals to collaborate with Pfizer’s Centers for Therapeutic Innovation (CTI). Pfizer’s CTI program, which is managed by NCATS, pairs NIH intramural researchers with Pfizer resources to pursue scientific and medical advances through joint therapeutic development. Goals include identifying biologic compounds with activity in a pathway or target of interest to both an NIH intramural researcher and Pfizer and moving the compounds into the clinic to test them. Areas of interest to Pfizer include cancer, autoimmunity/inflammation, metabolic … Continue reading

Apply for the 2018 Omnibus Grant

The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health invites small businesses to apply for funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) 2018 Omnibus Grant Solicitations: ·    SBIR: PA-18-574 ·    ​STTR: PA-18-575   NCATS encourages applications that address a range of focus areas relevant to any stage of translation, from target validation through pre-clinical and clinical evaluation, to intervention implementation and dissemination, including: ·    Drug Discovery and Development ·    Biomedical, Clinical and Health Research Informatics ·    Clinical, Dissemination and Implementation Research The next deadline to apply is Sept. 5, 2018, … Continue reading